Semler Scientific (NASDAQ:SMLR) Sets New 52-Week High – Still a Buy?

Shares of Semler Scientific, Inc. (NASDAQ:SMLR) hit a new 52-week high during trading on Thursday . The stock traded as high as $74.85 and last traded at $74.85, with a volume of 322944 shares trading hands. The stock had previously closed at $59.27.

Semler Scientific Stock Performance

The company’s 50-day moving average is $30.87 and its 200 day moving average is $30.27. The company has a market capitalization of $515.15 million, a PE ratio of 34.34 and a beta of 0.92.

Semler Scientific (NASDAQ:SMLR) last announced its quarterly earnings results on Monday, November 4th. The company reported $0.72 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.37 by $0.35. The firm had revenue of $13.51 million for the quarter. Semler Scientific had a net margin of 27.00% and a return on equity of 20.31%.

Insider Transactions at Semler Scientific

In other news, CEO Douglas Murphy-Chutorian sold 10,000 shares of Semler Scientific stock in a transaction that occurred on Thursday, August 29th. The shares were sold at an average price of $28.35, for a total transaction of $283,500.00. Following the sale, the chief executive officer now owns 60,220 shares in the company, valued at $1,707,237. This trade represents a 14.24 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Company insiders own 30.20% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of SMLR. Shariaportfolio Inc. purchased a new position in Semler Scientific during the third quarter worth $3,618,000. CWM LLC lifted its position in shares of Semler Scientific by 486.3% during the second quarter. CWM LLC now owns 897 shares of the company’s stock worth $31,000 after purchasing an additional 744 shares during the last quarter. Jacobs Levy Equity Management Inc. lifted its position in shares of Semler Scientific by 20.6% during the first quarter. Jacobs Levy Equity Management Inc. now owns 98,252 shares of the company’s stock worth $2,870,000 after purchasing an additional 16,777 shares during the last quarter. Dimensional Fund Advisors LP lifted its position in shares of Semler Scientific by 18.3% during the second quarter. Dimensional Fund Advisors LP now owns 126,177 shares of the company’s stock worth $4,341,000 after purchasing an additional 19,552 shares during the last quarter. Finally, AQR Capital Management LLC raised its holdings in shares of Semler Scientific by 150.1% in the second quarter. AQR Capital Management LLC now owns 140,498 shares of the company’s stock valued at $4,833,000 after acquiring an additional 84,314 shares in the last quarter. 49.37% of the stock is owned by hedge funds and other institutional investors.

About Semler Scientific

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.